Revenue

Warner Bros. Discovery pushes for a Netflix merger but opens a one-week window for Paramount Skydance to fix its flawed bid. A bidding war looms.

With a key depression drug nearing Phase 3 and more data imminent, AtaiBeckley is set to make its case to Wall Street at three major March conferences.

With all regulatory hurdles cleared, GDI makes a final push for shareholder approval on a $36.60 per share buyout from private equity firm Birch Hill.

How did a Tennessee 3PL achieve 18x shipment growth? A deep dive into the unified tech platform and AI strategy that’s rewriting the rules of freight.

The world's largest bedding company raises its dividend for the sixth time in five years, flexing financial muscle despite mixed signals from Wall Street.

With a massive dataset from $6.2B in prior authorizations, SamaCare's AI is speeding up access to critical drugs, but raises questions about market power.

Bausch Health heads to a key finance conference to address investor concerns over its massive debt, upcoming patent cliffs, and future strategic direction.

Brunswick Exploration launches a new drill program at a major Quebec lithium find, part of a global strategy in a surging market for critical minerals.

Despite a $70M net loss and falling sales, chemical firm Orion S.A. highlights positive free cash flow and a new focus on financial discipline.

Citing 'prolonged underperformance,' activist investor Starboard Value seeks to replace Tripadvisor's board, igniting a battle for control.

As Pasithea Therapeutics heads to a key investor conference, all eyes are on its lead drug, PAS-004, and its potential to treat rare and complex diseases.

Zefiro Methane founder accuses the board of entrenchment tactics, setting the stage for a critical BCSC hearing that will shape the company's future.

Two small businesses from Pennsylvania are finding massive success in Asia, leveraging Coupang's AI-powered platform to bypass traditional export hurdles.

A strategic merger creates a new aerospace and defense giant, but existing shareholders face significant dilution in a deal laden with both promise and risk.

As global leaders gather in Mumbai, the focus shifts from climate negotiation to concrete action, testing new tools to accelerate progress toward COP31.

With 13,000 attendees and a bold expansion to Ras Al Khaimah, AIBC Eurasia 2026 highlights a major shift of tech's center of power to the East.

Allocate's 350% asset growth signals a major shift as wealth advisors embrace private markets. Discover how its AI-powered platform is making it possible.

Montréal defied a turbulent year, welcoming 11.8M visitors and securing $5.8B in spending. Now, it's gearing up for its biggest year since the Olympics.

A new health tech company has assembled a star-studded scientific board to back its AI-powered dementia prevention app. But can it deliver on its promise?

VIAVI's new ePRTC360+ meets stringent timing standards without Cesium, offering a cheaper, more resilient solution for critical infrastructure.